Company intelligence / Profile preview

Popeyes

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

Popeye Marine Biotechnology is the world’s first company to develop marine biodiversity coral cultivation technology for use in high-quality medical materials and devices. Their main focus is on producing natural artificial culture of coral bio-materials, which are used as orthopedic bone graft substitutes and other advanced medical applications. The company collaborates with universities and biotech companies globally to support innovation in marine resource-based healthcare solutions[1][7][9].

Therapeutic areas: Other
Modalities: Medical deviceBiomaterial
Industry: Implantable Medical Devices

Partnerships

Collaborations with worldwide universities and related medical biotechnology companies[1]

Beyond the preview

Go deeper on Popeyes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Popeyes.

Explore the full profile